Michele Y. Splinter , Pharm.D., BCPS
Clinical Associate Professor
Department of Pharmacy: Clinical and Administrative Sciences
Research Summary
Specialties
Neurology, Pharmacokinetics
Research Interests
Neurology, Pharmacokinetics, Adult Medicine. Research includes thromboembolic prophylaxis and medication use in rehabilitation medicine.
Education & Experience
Education
- University of Oklahoma, Norman, Oklahoma. Received Bachelor of Science degree in Pharmacy in December, 1973, 1969-1973
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Received degree of Master in Pharmaceutical Sciences in May, 1988, 1986-1988
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Received degree of Doctor of Pharmacy in June, 1995, 1993-1995
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Postdoctoral Residency in Clinical Pharmacokinetics. Preceptor: Michael E. Burton, Pharm.D., 1995-1996
Professional Experience
- Staff Pharmacist, Southwest Medical Center of Oklahoma, 4401 S. Western, Oklahoma City, Oklahoma 73109 (1979-1994) 1979-1994
- Clinical Assistant Professor, Department of Pharmacy Practice, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Director of Pharmacy Practice Laboratory (June 1991-July 1993), Coordinator Hospital Practicum (January 1992-April 1996) 1991-1995
- Clinical Instructor, Department of Pharmacy Practice, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 1995-1996
- Consultant, IV Services of Oklahoma, Oklahoma City, Oklahoma 1996-1997
- Clinical Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, Coordinator Pharmaceutical Care Module IV: Neurology (2001-present), Therapeutic Drug Monitoring Service (July 1996-September 1997),
- Director of Pharmacy Practice Laboratory (June 1996-September 1997)• Clinical Specialist, Rehabilitation Medicine. Jim Thorpe Rehabilitation Hospital, Oklahoma City, Oklahoma (1998-2004) 1996-2003
- Clinical Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 2003-Present
Teaching Experience
- PHAR 7094 Clinical Rotation in Rehabilitation Medicine and Adult Medicine, October 1998-2004
- PHAR 7842 Co-Coordinator for Pharmaceutical Care Module IV: Neurology. Pharmacotherapy of Parkinson’s Disease, Pharmacotherapy for Headaches, Antiepileptic Pharmacokinetics, and Antiepileptic Pharmacotherapy, Spring 2000-present
- PHAR 7832 Clinical Pharmacokinetics of Psychotherapeutic Agents (2000-present) and Phenytoin (2004-present) for Clinical Pharmacokinetics
- PA 7106 Parkinson’s Disease and Seizures and Status Epilepticus for Pharmacotherapeutics, Spring 2000-present
- PERI 5012-PHSC 5012. Co-Coordinator Advanced Clinical Pharmacotherapeutics. Basic Principles of Clinical Pharmacology, Spring 2005.
- PHSC 5010 Seizures and Status Epilepticus for Clinical Pharmacotherapeutics, Spring 2000-04
- PHAR 7094 Neurology Selective (Pharm.D. students) 2006-present
Selected Publications & Presentations
- Splinter MY. Rotigotine—Transdermal dopamine agonist in treatment of Parkinson’s disease and restless legs syndrome. Ann Pharmacother 2007;41:285-95. DOI 10.1345/aph.1H113
- Splinter MY. Pharmacotherapy Teaching Service. Monograph 19 in Clinical Pharmacy Services: Innovative Practices in Community Hospitals, Koch K, Lobo B, eds. American College of Clinical Pharmacy, Kansas City, MO, 2005.
- Splinter MY. Chapter 16: Drug-Induced Cognitive Disease in Drug-Induced Diseases. Tisdale JE, Miller DA, eds. American Society of Health-System Pharmacists, Bethesda, 2005.
- Linnebur SA, O’Connell MB, Wessell AM, McCord A, Kennedy DH, DeMaagd G, Dent LA, Splinter MY, et al. Pharmacy Practice, Research, Education and Advocacy for older adults. Pharmacotherapy 2005; 26:1396-1430.
- Splinter MY. Pharmacokinetics of New Antiepileptic Medications. J Pharmacy Practice 2005;18:444-460.